• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Elevai Labs, Inc. - Common Stock (NQ: ELAB )

    0.1080 -0.0240 (-18.18%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 32,122,937
    Open 0.1057
    Bid (Size) 0.1007 (13)
    Ask (Size) 0.1020 (25)
    Prev. Close 0.1320
    Today's Range 0.0970 - 0.1098
    52wk Range 0.0781 - 4.244
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    11 Consumer Staples Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Why Phoenix Motor Shares Are Trading Higher By 150%; Here Are 20 Stocks Moving Premarket
    Via Benzinga

    Performance

    YTD
    -94.29%
    -94.29%
    1 Month
    -66.25%
    -66.25%
    3 Month
    -81.22%
    -81.22%
    6 Month
    -84.12%
    -84.12%
    1 Year
    -96.82%
    -96.82%

    More News

    Read More
    12 Consumer Staples Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    REPEAT: Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist Combinations
    From Elevai Labs Inc.
    Via GlobeNewswire
    Why Elevai Labs (ELAB) Stock Is Down 60% Today
    Via Benzinga
    Nasdaq Moves Lower; Levi Strauss Shares Slide
    Via Benzinga
    Crude Oil Jumps Over 4%; US Services PMI Revised Lower
    Via Benzinga
    Exposures Fossil Fuels
    Dow Dips Over 100 Points; US Jobless Claims Increase To 225,000
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Consumer Staples Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist Combinations
    From Elevai Labs Inc.
    Via GlobeNewswire
    Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Launch of Clinical Study Combining Its Flagship Topical Exosome Skincare Products with a Medical Aesthetic Energy Device
    From Elevai Labs Inc.
    Via GlobeNewswire
    7 Penny Stocks to Watch Now: ELAB, RJDG, BTTC, ATCH, CBDW, and More!
    Via AB Newswire
    Dow Gains Over 50 Points; Elevai Labs Shares Plummet
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Crude Oil Down Over 1%; US Manufacturing PMI Falls In September
    Via Benzinga
    Exposures Fossil Fuels
    US Stocks Edge Higher; Chicago Fed National Activity Increases In August
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    Elevai Labs Inc. Announces Pricing of $8.0 Million Public Offering
    From Elevai Labs Inc.
    Via GlobeNewswire
    Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Positive Results for E-Series Exosome Technology in Potential Melasma Applications
    From Elevai Labs Inc.
    Via GlobeNewswire
    Why GitLab Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Encouraging Data Results Indicating Potential for Hair Restoration Using Proprietary Exosome Technology
    From Elevai Labs Inc.
    Via GlobeNewswire
    12 Consumer Staples Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Elevai Labs Inc. Files Combination Patents with Yuva Biosciences for Breakthrough Hair and Scalp Care Technology Utilizing YuvaBioⓇ Y100™ Mitochondrial Innovation and Elevai Exosomes™
    From Elevai Labs Inc.
    Via GlobeNewswire
    Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Positive Data Results with Completion of Clinical Study of Elevai Enfinity™ Topical Exosome Serum
    From Elevai Labs Inc.
    Via GlobeNewswire
    Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Why Workday Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Elevai Labs Inc. Subsidiary, Elevai Research Inc., Announces Preliminary Positive Research Data Highlighting the Potential of Proprietary Exosome Technology for Skin Health Applications
    From Elevai Labs Inc.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.